Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response

Despite recent advances in melanoma treatment, there are still patients that either do not respond or develop resistance. This unresponsiveness and/or acquired resistance to therapy could be explained by the fact that some melanoma cells reside in a dedifferentiated state. Interestingly, this dediff...

Descripción completa

Detalles Bibliográficos
Autores principales: De Backer, Joey, Maric, Darko, Zuhra, Karim, Bogaerts, Annemie, Szabo, Csaba, Vanden Berghe, Wim, Hoogewijs, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405091/
https://www.ncbi.nlm.nih.gov/pubmed/36009267
http://dx.doi.org/10.3390/antiox11081548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405091/
https://www.ncbi.nlm.nih.gov/pubmed/36009267
http://dx.doi.org/10.3390/antiox11081548

Ejemplares similares